Browse by Audience
Skip to content
Papers of the Week
Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older.
Authors
Babaei M, Rapoport AMAbstract
Migraine is a prevalent, inherited, disabling brain disease with multiple symptoms and a variety of treatment options. Nerivio, utilising remote electrical neuromodulation (REN) a wearable device, offers users good efficacy, tolerability, and safety. It is user-friendly, affordable, non-addictive and cleared by the FDA and the European Conformity.